High Drug Prices Open Switzerland Up To Regional Procurement Ideas 07/02/2019 William New Switzerland, considered to be one of the richest countries in the world and home to significant medical research and development, has begun feeling the pressure of high drug prices for its citizens. This has led it to begin talking with other countries exploring joint procurement initiatives aimed at lowering prices, the Swiss global health ambassador told Health Policy Watch in a recent interview. Continue reading -> The ‘Year Of UHC’ – Interview With Swiss Global Health Amb. Nora Kronig Romero 07/02/2019 Health Policy Watch Universal health coverage, access to medicines, and noncommunicable diseases are priorities for Switzerland in global health policy. Amb. Nora Kronig Romero is the head of the International Affairs Division and Vice Director General of the Federal Office of Public Health, as well as Swiss Ambassador for Global Health. She sat down with Health Policy Watch while in Geneva last week for the meeting of the World Health Organization Executive Board, which Switzerland attended as an observer to the governing board comprised of 34 WHO member states. Continue reading -> Beat NCDs: Rwanda Celebrates First Car-Free Day, While Kenya Plans Air Pollution Sensors 04/02/2019 Elaine Ruth Fletcher Rwanda’s capital city, Kigali, celebrated its first car-free day today, while a Kenyan telecom company was reported to have launched a major initiative to install 3,000 low-cost air pollution sensors around the country, in response to growing fears about air pollution’s health impacts. Continue reading -> WHO Board Resorts To Vote To Settle Israel Request To Remove Palestine Agenda Item 01/02/2019 Catherine Saez In a rare occasion, the World Health Organization Executive Board today resorted to recorded voting to decide on a politically-charged question, as Israel requested the deletion of an agenda item for the next World Health Assembly relating to the health of Palestinians in occupied territories. The Board ultimately voted against removing the agenda item for the next WHA in May. Continue reading -> WHO Names Directors For Western Pacific, Southeast Asia 26/01/2019 William New The World Health Organization Executive Board today appointed the next directors for two of its its six regions. Continue reading -> Board Debates WHO Plans For Efficiencies At Headquarters & Funding Shifts To Countries 25/01/2019 Elaine Ruth Fletcher A massive restructuring of WHO’s 2020-2021 budget should see a shift away from siloed disease control programmes to a more integrated approach, focused on building health systems and strengthening country operations. These were the key strategic features of the proposed budget of US$ 4.785 billion, reviewed by WHO’s Executive Board in a lengthy session today. Continue reading -> Introducing The New Health Policy Watch Website 23/01/2019 William New Today marks the launch of a brand-new online platform for Health Policy Watch, www.healthpolicy-watch.org, which has been redesigned to bring the richest possible selection of stories and ideas about current issues under debate in global health policy circles – which directly or indirectly touch the well-being of nearly everyone on the planet. Continue reading -> Tafenoquine – Milestone In Journey Towards Malaria Elimination 23/01/2019 Elaine Ruth Fletcher Tafenoquine, the first new drug to be developed in over 60 years to treat relapsing malaria, has in fact been around since the late 1970s, when researchers with the US Walter Reed Army Institute of Research first took note of its antimalarial properties. But the drug’s potential to cure relapsing malaria caused by the Plasmodium vivax parasite, the less deadly but most widespread malaria species, has only been recently been recognised. Continue reading -> Amazonian Quest For P Vivax Malaria Solutions 23/01/2019 Elaine Ruth Fletcher Alejandro Llanos-Cuentas has been fighting P vivax malaria in Peru throughout most of his professional life. For many years, he failed to see significant inroads in control of the disease, which is most prevalent in the remote communities of the country’s Amazon region. Continue reading -> Video: Stopping Malaria Relapse – New Approaches For An Old Disease 22/01/2019 Editorial team Medicines for Malaria Venture (MMV) tells the story of the new single-dose tefanoquine treatment for relapsing malaria, caused by the Plasmodium vivax species of the parasite – the most widespread in the world. Continue reading -> Posts navigation Older postsNewer posts
The ‘Year Of UHC’ – Interview With Swiss Global Health Amb. Nora Kronig Romero 07/02/2019 Health Policy Watch Universal health coverage, access to medicines, and noncommunicable diseases are priorities for Switzerland in global health policy. Amb. Nora Kronig Romero is the head of the International Affairs Division and Vice Director General of the Federal Office of Public Health, as well as Swiss Ambassador for Global Health. She sat down with Health Policy Watch while in Geneva last week for the meeting of the World Health Organization Executive Board, which Switzerland attended as an observer to the governing board comprised of 34 WHO member states. Continue reading -> Beat NCDs: Rwanda Celebrates First Car-Free Day, While Kenya Plans Air Pollution Sensors 04/02/2019 Elaine Ruth Fletcher Rwanda’s capital city, Kigali, celebrated its first car-free day today, while a Kenyan telecom company was reported to have launched a major initiative to install 3,000 low-cost air pollution sensors around the country, in response to growing fears about air pollution’s health impacts. Continue reading -> WHO Board Resorts To Vote To Settle Israel Request To Remove Palestine Agenda Item 01/02/2019 Catherine Saez In a rare occasion, the World Health Organization Executive Board today resorted to recorded voting to decide on a politically-charged question, as Israel requested the deletion of an agenda item for the next World Health Assembly relating to the health of Palestinians in occupied territories. The Board ultimately voted against removing the agenda item for the next WHA in May. Continue reading -> WHO Names Directors For Western Pacific, Southeast Asia 26/01/2019 William New The World Health Organization Executive Board today appointed the next directors for two of its its six regions. Continue reading -> Board Debates WHO Plans For Efficiencies At Headquarters & Funding Shifts To Countries 25/01/2019 Elaine Ruth Fletcher A massive restructuring of WHO’s 2020-2021 budget should see a shift away from siloed disease control programmes to a more integrated approach, focused on building health systems and strengthening country operations. These were the key strategic features of the proposed budget of US$ 4.785 billion, reviewed by WHO’s Executive Board in a lengthy session today. Continue reading -> Introducing The New Health Policy Watch Website 23/01/2019 William New Today marks the launch of a brand-new online platform for Health Policy Watch, www.healthpolicy-watch.org, which has been redesigned to bring the richest possible selection of stories and ideas about current issues under debate in global health policy circles – which directly or indirectly touch the well-being of nearly everyone on the planet. Continue reading -> Tafenoquine – Milestone In Journey Towards Malaria Elimination 23/01/2019 Elaine Ruth Fletcher Tafenoquine, the first new drug to be developed in over 60 years to treat relapsing malaria, has in fact been around since the late 1970s, when researchers with the US Walter Reed Army Institute of Research first took note of its antimalarial properties. But the drug’s potential to cure relapsing malaria caused by the Plasmodium vivax parasite, the less deadly but most widespread malaria species, has only been recently been recognised. Continue reading -> Amazonian Quest For P Vivax Malaria Solutions 23/01/2019 Elaine Ruth Fletcher Alejandro Llanos-Cuentas has been fighting P vivax malaria in Peru throughout most of his professional life. For many years, he failed to see significant inroads in control of the disease, which is most prevalent in the remote communities of the country’s Amazon region. Continue reading -> Video: Stopping Malaria Relapse – New Approaches For An Old Disease 22/01/2019 Editorial team Medicines for Malaria Venture (MMV) tells the story of the new single-dose tefanoquine treatment for relapsing malaria, caused by the Plasmodium vivax species of the parasite – the most widespread in the world. Continue reading -> Posts navigation Older postsNewer posts
Beat NCDs: Rwanda Celebrates First Car-Free Day, While Kenya Plans Air Pollution Sensors 04/02/2019 Elaine Ruth Fletcher Rwanda’s capital city, Kigali, celebrated its first car-free day today, while a Kenyan telecom company was reported to have launched a major initiative to install 3,000 low-cost air pollution sensors around the country, in response to growing fears about air pollution’s health impacts. Continue reading -> WHO Board Resorts To Vote To Settle Israel Request To Remove Palestine Agenda Item 01/02/2019 Catherine Saez In a rare occasion, the World Health Organization Executive Board today resorted to recorded voting to decide on a politically-charged question, as Israel requested the deletion of an agenda item for the next World Health Assembly relating to the health of Palestinians in occupied territories. The Board ultimately voted against removing the agenda item for the next WHA in May. Continue reading -> WHO Names Directors For Western Pacific, Southeast Asia 26/01/2019 William New The World Health Organization Executive Board today appointed the next directors for two of its its six regions. Continue reading -> Board Debates WHO Plans For Efficiencies At Headquarters & Funding Shifts To Countries 25/01/2019 Elaine Ruth Fletcher A massive restructuring of WHO’s 2020-2021 budget should see a shift away from siloed disease control programmes to a more integrated approach, focused on building health systems and strengthening country operations. These were the key strategic features of the proposed budget of US$ 4.785 billion, reviewed by WHO’s Executive Board in a lengthy session today. Continue reading -> Introducing The New Health Policy Watch Website 23/01/2019 William New Today marks the launch of a brand-new online platform for Health Policy Watch, www.healthpolicy-watch.org, which has been redesigned to bring the richest possible selection of stories and ideas about current issues under debate in global health policy circles – which directly or indirectly touch the well-being of nearly everyone on the planet. Continue reading -> Tafenoquine – Milestone In Journey Towards Malaria Elimination 23/01/2019 Elaine Ruth Fletcher Tafenoquine, the first new drug to be developed in over 60 years to treat relapsing malaria, has in fact been around since the late 1970s, when researchers with the US Walter Reed Army Institute of Research first took note of its antimalarial properties. But the drug’s potential to cure relapsing malaria caused by the Plasmodium vivax parasite, the less deadly but most widespread malaria species, has only been recently been recognised. Continue reading -> Amazonian Quest For P Vivax Malaria Solutions 23/01/2019 Elaine Ruth Fletcher Alejandro Llanos-Cuentas has been fighting P vivax malaria in Peru throughout most of his professional life. For many years, he failed to see significant inroads in control of the disease, which is most prevalent in the remote communities of the country’s Amazon region. Continue reading -> Video: Stopping Malaria Relapse – New Approaches For An Old Disease 22/01/2019 Editorial team Medicines for Malaria Venture (MMV) tells the story of the new single-dose tefanoquine treatment for relapsing malaria, caused by the Plasmodium vivax species of the parasite – the most widespread in the world. Continue reading -> Posts navigation Older postsNewer posts
WHO Board Resorts To Vote To Settle Israel Request To Remove Palestine Agenda Item 01/02/2019 Catherine Saez In a rare occasion, the World Health Organization Executive Board today resorted to recorded voting to decide on a politically-charged question, as Israel requested the deletion of an agenda item for the next World Health Assembly relating to the health of Palestinians in occupied territories. The Board ultimately voted against removing the agenda item for the next WHA in May. Continue reading -> WHO Names Directors For Western Pacific, Southeast Asia 26/01/2019 William New The World Health Organization Executive Board today appointed the next directors for two of its its six regions. Continue reading -> Board Debates WHO Plans For Efficiencies At Headquarters & Funding Shifts To Countries 25/01/2019 Elaine Ruth Fletcher A massive restructuring of WHO’s 2020-2021 budget should see a shift away from siloed disease control programmes to a more integrated approach, focused on building health systems and strengthening country operations. These were the key strategic features of the proposed budget of US$ 4.785 billion, reviewed by WHO’s Executive Board in a lengthy session today. Continue reading -> Introducing The New Health Policy Watch Website 23/01/2019 William New Today marks the launch of a brand-new online platform for Health Policy Watch, www.healthpolicy-watch.org, which has been redesigned to bring the richest possible selection of stories and ideas about current issues under debate in global health policy circles – which directly or indirectly touch the well-being of nearly everyone on the planet. Continue reading -> Tafenoquine – Milestone In Journey Towards Malaria Elimination 23/01/2019 Elaine Ruth Fletcher Tafenoquine, the first new drug to be developed in over 60 years to treat relapsing malaria, has in fact been around since the late 1970s, when researchers with the US Walter Reed Army Institute of Research first took note of its antimalarial properties. But the drug’s potential to cure relapsing malaria caused by the Plasmodium vivax parasite, the less deadly but most widespread malaria species, has only been recently been recognised. Continue reading -> Amazonian Quest For P Vivax Malaria Solutions 23/01/2019 Elaine Ruth Fletcher Alejandro Llanos-Cuentas has been fighting P vivax malaria in Peru throughout most of his professional life. For many years, he failed to see significant inroads in control of the disease, which is most prevalent in the remote communities of the country’s Amazon region. Continue reading -> Video: Stopping Malaria Relapse – New Approaches For An Old Disease 22/01/2019 Editorial team Medicines for Malaria Venture (MMV) tells the story of the new single-dose tefanoquine treatment for relapsing malaria, caused by the Plasmodium vivax species of the parasite – the most widespread in the world. Continue reading -> Posts navigation Older postsNewer posts
WHO Names Directors For Western Pacific, Southeast Asia 26/01/2019 William New The World Health Organization Executive Board today appointed the next directors for two of its its six regions. Continue reading -> Board Debates WHO Plans For Efficiencies At Headquarters & Funding Shifts To Countries 25/01/2019 Elaine Ruth Fletcher A massive restructuring of WHO’s 2020-2021 budget should see a shift away from siloed disease control programmes to a more integrated approach, focused on building health systems and strengthening country operations. These were the key strategic features of the proposed budget of US$ 4.785 billion, reviewed by WHO’s Executive Board in a lengthy session today. Continue reading -> Introducing The New Health Policy Watch Website 23/01/2019 William New Today marks the launch of a brand-new online platform for Health Policy Watch, www.healthpolicy-watch.org, which has been redesigned to bring the richest possible selection of stories and ideas about current issues under debate in global health policy circles – which directly or indirectly touch the well-being of nearly everyone on the planet. Continue reading -> Tafenoquine – Milestone In Journey Towards Malaria Elimination 23/01/2019 Elaine Ruth Fletcher Tafenoquine, the first new drug to be developed in over 60 years to treat relapsing malaria, has in fact been around since the late 1970s, when researchers with the US Walter Reed Army Institute of Research first took note of its antimalarial properties. But the drug’s potential to cure relapsing malaria caused by the Plasmodium vivax parasite, the less deadly but most widespread malaria species, has only been recently been recognised. Continue reading -> Amazonian Quest For P Vivax Malaria Solutions 23/01/2019 Elaine Ruth Fletcher Alejandro Llanos-Cuentas has been fighting P vivax malaria in Peru throughout most of his professional life. For many years, he failed to see significant inroads in control of the disease, which is most prevalent in the remote communities of the country’s Amazon region. Continue reading -> Video: Stopping Malaria Relapse – New Approaches For An Old Disease 22/01/2019 Editorial team Medicines for Malaria Venture (MMV) tells the story of the new single-dose tefanoquine treatment for relapsing malaria, caused by the Plasmodium vivax species of the parasite – the most widespread in the world. Continue reading -> Posts navigation Older postsNewer posts
Board Debates WHO Plans For Efficiencies At Headquarters & Funding Shifts To Countries 25/01/2019 Elaine Ruth Fletcher A massive restructuring of WHO’s 2020-2021 budget should see a shift away from siloed disease control programmes to a more integrated approach, focused on building health systems and strengthening country operations. These were the key strategic features of the proposed budget of US$ 4.785 billion, reviewed by WHO’s Executive Board in a lengthy session today. Continue reading -> Introducing The New Health Policy Watch Website 23/01/2019 William New Today marks the launch of a brand-new online platform for Health Policy Watch, www.healthpolicy-watch.org, which has been redesigned to bring the richest possible selection of stories and ideas about current issues under debate in global health policy circles – which directly or indirectly touch the well-being of nearly everyone on the planet. Continue reading -> Tafenoquine – Milestone In Journey Towards Malaria Elimination 23/01/2019 Elaine Ruth Fletcher Tafenoquine, the first new drug to be developed in over 60 years to treat relapsing malaria, has in fact been around since the late 1970s, when researchers with the US Walter Reed Army Institute of Research first took note of its antimalarial properties. But the drug’s potential to cure relapsing malaria caused by the Plasmodium vivax parasite, the less deadly but most widespread malaria species, has only been recently been recognised. Continue reading -> Amazonian Quest For P Vivax Malaria Solutions 23/01/2019 Elaine Ruth Fletcher Alejandro Llanos-Cuentas has been fighting P vivax malaria in Peru throughout most of his professional life. For many years, he failed to see significant inroads in control of the disease, which is most prevalent in the remote communities of the country’s Amazon region. Continue reading -> Video: Stopping Malaria Relapse – New Approaches For An Old Disease 22/01/2019 Editorial team Medicines for Malaria Venture (MMV) tells the story of the new single-dose tefanoquine treatment for relapsing malaria, caused by the Plasmodium vivax species of the parasite – the most widespread in the world. Continue reading -> Posts navigation Older postsNewer posts
Introducing The New Health Policy Watch Website 23/01/2019 William New Today marks the launch of a brand-new online platform for Health Policy Watch, www.healthpolicy-watch.org, which has been redesigned to bring the richest possible selection of stories and ideas about current issues under debate in global health policy circles – which directly or indirectly touch the well-being of nearly everyone on the planet. Continue reading -> Tafenoquine – Milestone In Journey Towards Malaria Elimination 23/01/2019 Elaine Ruth Fletcher Tafenoquine, the first new drug to be developed in over 60 years to treat relapsing malaria, has in fact been around since the late 1970s, when researchers with the US Walter Reed Army Institute of Research first took note of its antimalarial properties. But the drug’s potential to cure relapsing malaria caused by the Plasmodium vivax parasite, the less deadly but most widespread malaria species, has only been recently been recognised. Continue reading -> Amazonian Quest For P Vivax Malaria Solutions 23/01/2019 Elaine Ruth Fletcher Alejandro Llanos-Cuentas has been fighting P vivax malaria in Peru throughout most of his professional life. For many years, he failed to see significant inroads in control of the disease, which is most prevalent in the remote communities of the country’s Amazon region. Continue reading -> Video: Stopping Malaria Relapse – New Approaches For An Old Disease 22/01/2019 Editorial team Medicines for Malaria Venture (MMV) tells the story of the new single-dose tefanoquine treatment for relapsing malaria, caused by the Plasmodium vivax species of the parasite – the most widespread in the world. Continue reading -> Posts navigation Older postsNewer posts
Tafenoquine – Milestone In Journey Towards Malaria Elimination 23/01/2019 Elaine Ruth Fletcher Tafenoquine, the first new drug to be developed in over 60 years to treat relapsing malaria, has in fact been around since the late 1970s, when researchers with the US Walter Reed Army Institute of Research first took note of its antimalarial properties. But the drug’s potential to cure relapsing malaria caused by the Plasmodium vivax parasite, the less deadly but most widespread malaria species, has only been recently been recognised. Continue reading -> Amazonian Quest For P Vivax Malaria Solutions 23/01/2019 Elaine Ruth Fletcher Alejandro Llanos-Cuentas has been fighting P vivax malaria in Peru throughout most of his professional life. For many years, he failed to see significant inroads in control of the disease, which is most prevalent in the remote communities of the country’s Amazon region. Continue reading -> Video: Stopping Malaria Relapse – New Approaches For An Old Disease 22/01/2019 Editorial team Medicines for Malaria Venture (MMV) tells the story of the new single-dose tefanoquine treatment for relapsing malaria, caused by the Plasmodium vivax species of the parasite – the most widespread in the world. Continue reading -> Posts navigation Older postsNewer posts
Amazonian Quest For P Vivax Malaria Solutions 23/01/2019 Elaine Ruth Fletcher Alejandro Llanos-Cuentas has been fighting P vivax malaria in Peru throughout most of his professional life. For many years, he failed to see significant inroads in control of the disease, which is most prevalent in the remote communities of the country’s Amazon region. Continue reading -> Video: Stopping Malaria Relapse – New Approaches For An Old Disease 22/01/2019 Editorial team Medicines for Malaria Venture (MMV) tells the story of the new single-dose tefanoquine treatment for relapsing malaria, caused by the Plasmodium vivax species of the parasite – the most widespread in the world. Continue reading -> Posts navigation Older postsNewer posts
Video: Stopping Malaria Relapse – New Approaches For An Old Disease 22/01/2019 Editorial team Medicines for Malaria Venture (MMV) tells the story of the new single-dose tefanoquine treatment for relapsing malaria, caused by the Plasmodium vivax species of the parasite – the most widespread in the world. Continue reading -> Posts navigation Older postsNewer posts